611 XTX202–01/02–001, Phase 1/2 first-in human study of XTX202, a masked, tumor-activated IL-2βγ, in patients with advanced solid tumors: results from phase 1

• David Miller,
• John Powderly,
• Suthee Rapisuwon,
• Sanjay Goel,
• Bartosz Chmielowski,
• Richard Wu,
• Meredith McKean,
• Damiano Fantini,
• Yousef Zakharia,
• Jacob Thomas,
• Diana Hanna,
• Anthony El-Khoueiry,
• Ekta Patel,
• Anurag Gupta,
• George Lee,
• Meghan Duncan,
• Meredith Pelster,
• Randy Hurley,
• Aika Siu,
• David Crowe,
• Sattanathan Paramasivan,
• Katarina Luptakova

Affiliations

David Miller

Open Health Care, London, UK

John Powderly

10Carolina Biooncology Institute, Huntersville, NC, USA

Suthee Rapisuwon

Lombardi Comprehensive Cancer Center, MedStar Georgetown University Hospital, Washington, District of Columbia, USA

Sanjay Goel

Montefiore Medical Center, Albert Einstein College of Medicine, New York, New York, USA

Bartosz Chmielowski

7University of California Los Angeles, Jonsson Comprehensive Cancer Center, Los Angeles, CA, USA

Richard Wu

Aff1 grid.240145.60000000122914776MD Anderson Houston TX USA

Meredith McKean

5Sarah Cannon Research Institute, Nashville, TN, USA

Damiano Fantini

Eli Lilly and Company, Indianapolis, Indiana, USA

Yousef Zakharia

Department of Medicine, University of Iowa Holden Comprehensive Cancer Center, Iowa City, Iowa, USA

Jacob Thomas

2Keck School of Medicine of USC, Los Angeles, CA, USA

Diana Hanna

41Division of Medical Oncology, University of Southern California, Hoag Family Cancer Institute, Newport Beach, California, USA

Anthony El-Khoueiry

4USC Norris Comprehensive Cancer Center, Los Angeles, CA, USA

Ekta Patel

2Xilio Therapeutics, waltham, MA, USA

Anurag Gupta

1 Department of Visceral and Transplantation Surgery, Swiss HPB Centre, University Hospital Zurich, Zurich, Switzerland

George Lee

11Xilio Therapeutics, Waltham, MA, USA

Meghan Duncan

Xilio Therapeutics, Waltham, Massachusetts, USA

Meredith Pelster

4Sarah Cannon Research Institute, Nashville, TN, USA

Randy Hurley

4HealthPartners Cancer Center at Regions Hospital, Saint Paul, MN, USA

Aika Siu

11Xilio Therapeutics, Waltham, MA, USA

David Crowe

11Xilio Therapeutics, Waltham, MA, USA

Sattanathan Paramasivan

11Xilio Therapeutics, Waltham, MA, USA

Katarina Luptakova

11Xilio Therapeutics, Waltham, MA, USA